Table1_Variable clinical expression of a Belgian TGFB3 founder variant suggests the presence of a genetic modifier.DOCX

Background:TGFB3 variants cause Loeys–Dietz syndrome type 5, a syndromic form of thoracic aortic aneurysm and dissection. The exact disease phenotype is hard to delineate because of few identified cases and highly variable clinical representation. Methodology: We provide the results of a haplotype analysis and a medical record review of clinical features of 27 individuals from 5 different families, originating from the Campine region in Flanders, carrying the NM_003239.5(TGFB3):c.787G>C p.(Asp263His) likely pathogenic variant, dbSNP:rs796051886, ClinVar:203492. The Asp 263 residue is essent... Mehr ...

Verfasser: Melanie H. A. M. Perik
Emmanuela Govaerts
Steven Laga
Inge Goovaerts
Johan Saenen
Emeline Van Craenenbroeck
Josephina A. N. Meester
Ilse Luyckx
Inez Rodrigus
Aline Verstraeten
Lut Van Laer
Bart L. Loeys
Dokumenttyp: Dataset
Erscheinungsdatum: 2023
Schlagwörter: Genetics / Genetic Engineering / Biomarkers / Developmental Genetics (incl. Sex Determination) / Epigenetics (incl. Genome Methylation and Epigenomics) / Gene Expression (incl. Microarray and other genome-wide approaches) / Genome Structure and Regulation / Genomics / Genetically Modified Animals / Livestock Cloning / Gene and Molecular Therapy / Loeys–Dietz syndrome (LDS) / TGFB3 / thoracic aortic aneurysm and dissection (TAAD) / founder / genetic modifiers / connective tissue disorder / variable expressivity
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-26528483
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3389/fgene.2023.1251675.s001